Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
The report details the trend, potential and market size of Eosinophilic Esophagitis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Eosinophilic Esophagitis Drugmarket, defines the market attractiveness level of Eosinophilic Esophagitis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Eosinophilic Esophagitis Drug industry, describes the types of Eosinophilic Esophagitis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Eosinophilic Esophagitis Drug market and the development prospects and opportunities of Eosinophilic Esophagitis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Eosinophilic Esophagitis Drug market in Chapter 13.
By Player:
Adare Pharmaceuticals
AstraZeneca
Bayer
Celgene
GSK
Shire
Calypso
Quorum Innovations
DBV Technologies
Regeneron
Dr Falk Pharma
By Type:
Budesonide
Fluticasone
Others
By End-User:
Hospitals
Clinics
Drugstore
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Eosinophilic Esophagitis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Eosinophilic Esophagitis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Eosinophilic Esophagitis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Eosinophilic Esophagitis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Eosinophilic Esophagitis Drug Market Analysis and Outlook to 2022
-
7.1 Global Eosinophilic Esophagitis Drug Consumption (2017-2022)
-
7.2 United States Eosinophilic Esophagitis Drug Consumption (2017-2022)
-
7.3 Europe Eosinophilic Esophagitis Drug Consumption (2017-2022)
-
7.4 China Eosinophilic Esophagitis Drug Consumption (2017-2022)
-
7.5 Japan Eosinophilic Esophagitis Drug Consumption (2017-2022)
-
7.6 India Eosinophilic Esophagitis Drug Consumption (2017-2022)
-
7.7 South Korea Eosinophilic Esophagitis Drug Consumption (2017-2022)
8 Region and Country-wise Eosinophilic Esophagitis Drug Market Analysis and Outlook to 2028
-
8.1 Global Eosinophilic Esophagitis Drug Consumption Forecast (2022-2028)
-
8.2 United States Eosinophilic Esophagitis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Eosinophilic Esophagitis Drug Consumption Forecast (2022-2028)
-
8.4 China Eosinophilic Esophagitis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Eosinophilic Esophagitis Drug Consumption Forecast (2022-2028)
-
8.6 India Eosinophilic Esophagitis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Eosinophilic Esophagitis Drug Consumption Forecast (2022-2028)
9 Global Eosinophilic Esophagitis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Eosinophilic Esophagitis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Budesonide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Fluticasone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Eosinophilic Esophagitis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drugstore Consumption and Growth Rate (2017-2022)
10 Global Eosinophilic Esophagitis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Budesonide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Fluticasone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
11 Global Eosinophilic Esophagitis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Eosinophilic Esophagitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Eosinophilic Esophagitis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Eosinophilic Esophagitis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Eosinophilic Esophagitis Drug Market Competitive Analysis
-
14.1 Adare Pharmaceuticals
-
14.1.1 Adare Pharmaceuticals Company Details
-
14.1.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Eosinophilic Esophagitis Drug Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Eosinophilic Esophagitis Drug Product and Service
-
14.4 Celgene
-
14.4.1 Celgene Company Details
-
14.4.2 Celgene Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Celgene Eosinophilic Esophagitis Drug Product and Service
-
14.5 GSK
-
14.5.1 GSK Company Details
-
14.5.2 GSK Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GSK Eosinophilic Esophagitis Drug Product and Service
-
14.6 Shire
-
14.6.1 Shire Company Details
-
14.6.2 Shire Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Shire Eosinophilic Esophagitis Drug Product and Service
-
14.7 Calypso
-
14.7.1 Calypso Company Details
-
14.7.2 Calypso Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Calypso Eosinophilic Esophagitis Drug Product and Service
-
14.8 Quorum Innovations
-
14.8.1 Quorum Innovations Company Details
-
14.8.2 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Quorum Innovations Eosinophilic Esophagitis Drug Product and Service
-
14.9 DBV Technologies
-
14.9.1 DBV Technologies Company Details
-
14.9.2 DBV Technologies Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 DBV Technologies Eosinophilic Esophagitis Drug Product and Service
-
14.10 Regeneron
-
14.10.1 Regeneron Company Details
-
14.10.2 Regeneron Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Regeneron Eosinophilic Esophagitis Drug Product and Service
-
14.11 Dr Falk Pharma
-
14.11.1 Dr Falk Pharma Company Details
-
14.11.2 Dr Falk Pharma Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Dr Falk Pharma Eosinophilic Esophagitis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Eosinophilic Esophagitis Drug
-
Figure Eosinophilic Esophagitis Drug Picture
-
Table Global Eosinophilic Esophagitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Eosinophilic Esophagitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Eosinophilic Esophagitis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Eosinophilic Esophagitis Drug Consumption by Country (2017-2022)
-
Figure United States Eosinophilic Esophagitis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Eosinophilic Esophagitis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Eosinophilic Esophagitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Eosinophilic Esophagitis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Eosinophilic Esophagitis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Eosinophilic Esophagitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Eosinophilic Esophagitis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Eosinophilic Esophagitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Budesonide Consumption and Growth Rate (2017-2022)
-
Figure Global Fluticasone Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstore Consumption and Growth Rate (2017-2022)
-
Figure Global Budesonide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fluticasone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Eosinophilic Esophagitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Eosinophilic Esophagitis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Adare Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Eosinophilic Esophagitis Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Eosinophilic Esophagitis Drug Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Eosinophilic Esophagitis Drug Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Eosinophilic Esophagitis Drug Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Eosinophilic Esophagitis Drug Product and Service
-
Table Calypso (Foundation Year, Company Profile and etc.)
-
Table Calypso Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Calypso Eosinophilic Esophagitis Drug Product and Service
-
Table Quorum Innovations (Foundation Year, Company Profile and etc.)
-
Table Quorum Innovations Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quorum Innovations Eosinophilic Esophagitis Drug Product and Service
-
Table DBV Technologies (Foundation Year, Company Profile and etc.)
-
Table DBV Technologies Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table DBV Technologies Eosinophilic Esophagitis Drug Product and Service
-
Table Regeneron (Foundation Year, Company Profile and etc.)
-
Table Regeneron Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Eosinophilic Esophagitis Drug Product and Service
-
Table Dr Falk Pharma (Foundation Year, Company Profile and etc.)
-
Table Dr Falk Pharma Eosinophilic Esophagitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Falk Pharma Eosinophilic Esophagitis Drug Product and Service
-
